MULTI SCIENCES
Mouse IL-1beta ELISA Kit Plate
Mouse IL-1beta ELISA Kit Plate
SKU:EK201B
Product Details
| Brand | MultiSciences |
|---|---|
| CatNum | 70-EK201B |
| Product Name | Mouse IL-1beta ELISA Kit |
| Customs Name | Mouse IL-1beta ELISA Kit |
| Application | ELISA |
| Reactivity | Mouse |
| Assay Type | Sandwich ELISA |
| Suitable Sample Type | serum, plasma, cell culture supernates |
| Format | 96-well strip plate |
| Storage | 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened) |
| Shipping Condition | 4℃ |
| Sample Volume | 20 μl |
| Sensitivity | 4.28 pg/ml |
| Standard Curve Range | 15.63 - 1000 pg/ml |
| Spike Recovery Range | 83 % - 109 % |
| Mean Spike Recovery | 0.97 |
| CV of Intra plate | 4.2 % - 8.4 % |
| CV of Inter plate | 2.8 % - 5.6 % |
| Release Date | 2016/8/20 |
| Components | 96-well polystyrene microplate coated with a monoclonal antibody against Mouse IL-1β Mouse IL-1β Standard, lyophilized Mouse IL-1β Detect Antibody Standard Diluent Streptavidin-HRP Assay Buffer (10×) Substrate (TMB) Stop Solution washing Buffer (20×) Plate Covers |
| Describtion | This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse IL-1β. The Mouse IL-1β ELISA is for research use only. Not for diagnostic or therapeutic procedures. Interleukin-1 (IL-1) is an extracellular peptide of 17 kDa that designates two proteins, IL-1α and IL-1β. IL-1β is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis.The interleukin-1 (IL-1) species represent an important family of biologically active mono nuclear cell-derived proteins which are involved in inflammatory reactions and in immune responses. Increased production of IL-1β causes a number of different autoinflammatory syndromes, most notably the monogenic conditions referred to as CAPS, due to mutations in the inflammasome receptor NLRP3 which triggers processing of IL-1β. |
